<i>In Vivo–In Vitro</i> Correlations: Predicting Pulmonary Drug Deposition from Pharmaceutical AerosolsPeter R. Byron, Warren H. Finlay, Michael J. Oldham et al.|Journal of Aerosol Medicine and Pulmonary Drug Delivery|2010Cited by 115
Dose emissions from marketed dry powder inhalersMichael Hindle, Peter R. Byron|International Journal of Pharmaceutics|1995Cited by 107
Numerical Simulations of Capillary Aerosol Generation: CFD Model Development and Comparisons with Experimental DataP. Worth Longest, Peter R. Byron, Michael Hindle et al.|Aerosol Science and Technology|2007Cited by 97
<i>In Vitro</i> Tests for Aerosol Deposition II: IVIVCs for Different Dry Powder Inhalers in Normal AdultsRenishkumar Delvadia, Peter R. Byron, Michael Hindle et al.|Journal of Aerosol Medicine and Pulmonary Drug Delivery|2012Cited by 90
<i>In Vitro</i> Tests for Aerosol Deposition. VI: Realistic Testing with Different Mouth–Throat Models and <i>In Vitro—In Vivo</i> Correlations for a Dry Powder Inhaler, Metered Dose Inhaler, and Soft Mist InhalerXiangyin Wei, Peter R. Byron, Renishkumar Delvadia et al.|Journal of Aerosol Medicine and Pulmonary Drug Delivery|2018Cited by 73